• Antin, J.H., Childs, R., Filipovich, A.H., Giralt, S., Mackinnon, S., Spitzer, T. & Weisdorf, D. (2001) Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 7, 473485.
  • Bellucci, R., Wu, C.J., Chiaretti, S., Weller, E., Davies, F.E., Alyea, E.P., Dranoff, G., Anderson, K.C., Munshi, N.C., & Ritz, J. (2004) Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens. Blood, 103, 656663.
  • Benjamin, R.J., Connors, J.M., McGurk, S., Churchill, W.H. & Antin, J.H. (1998) Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biology of Blood and Marrow Transplantation, 4, 151156.
  • Berentsen, S., Ulvestad, E., Gjertsen, B.T., Hjorth-Hansen, H., Langholm, R., Knutsen, H., Ghanima, W., Shammas, F.V. & Tjonnfjord, G.E. (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood, 103, 29252928.
  • Bolan, C.D., Leitman, S.F., Griffith, L.M., Wesley, R.A., Procter, J.L., Stroncek, D.F., Barrett, A.J. & Childs, R.W. (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood, 98, 16871694
  • Bolan, C.D., Leitman, S.F., Griffith, L.M., Barrett, A.J. & Childs, R.W. (2002) Correspondence to the editor: parameters of erythropoietic function after major ABO-incompatible hematopoietic stem cell transplantation: implications following nonmyeloablative conditioning. Blood, 99, 46424644.
  • Cartron, G., Watier, H., Golay, J. & Solal-Celigny, P. (2004) From bench to the bedside: ways to improve rituximab efficacy. Blood, 104, 26352642.
  • Carvallo, C., Geller, N., Kurlander, R., Srinivasan, R., Mena, O., Igarashi, T., Griffith, L.M., Linehan, W.M. & Childs, R.W. (2004) Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors. Blood 103, 15601563.
  • Childs, R., Clave, E., Contentin, N., Jayasekera, D., Nensel, N., Leitman, S., Read, E.J., Carter, C., Bahceci, E., Young, N.S. & Barrett, A.J. (1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses. Blood, 94, 32343241.
  • Childs, R., Chernoff, A., Contenin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E.J., Tisdale, J., Dunbar, C., Linehan, W.M., Young, N.S. & Barrett, A.J. (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. New England Journal of Medicine, 343, 750758.
  • Chilosi, M., Adami, F., Lestani, M., Montagna, L., Cimarosto, L., Semenzato, G., Pizzolo, G. & Menestrina, F. (1999) CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Modern Pathology, 12, 11011106.
  • Dodds, A.J. (2004) ABO incompatibility and blood product support. In: Clinical Bone Marrow and Blood Stem Cell Transplantation, 3rd edn (ed. by K.Atkinson, R.Champlin, J.Ritz, W.J.Fibbe, P.Ljungman & M.K.Brenner), pp. 10771087. Cambridge University Press, Cambridge, UK.
  • Holloway, P.A., Kaldenhoven, N., Kok-Schoemaker, H.M., Van Kessel, B., Van Blokland, W.T.M., Bloem, A.C. & Lokhorst, H.M. (2003) Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma. Clinical and Experimental Immunology, 131, 340346.
  • Jennings, D. & Foon, K.A. (1997) Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood, 90, 28632892.
  • Lee, J.H., Lee, J.H., Choi, S.J., Kim, S., Seol, M., Kwon, S.W., Park, C.J., Chi, H.S., Lee, J.S., Kim, W.K. & Lee, K.H. (2003) Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. British Journal of Haematology, 120, 702710.
  • Luft, T., Moos, M., Goldschmidt, H., Ho, A.D. & Gomer, M. (2003) Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma. British Journal of Haematology, 123, 646653.
  • Maloney, D.G., Molina, A.J., Sahebi, F., Stockerl-Goldstein, K.E., Sandmaier, B.M., Bensinger, W., Storer, B., Hegenbart, U., Somlo, G., Chauncey, T., Bruno, B., Appelbaum, F.R., Blume, K.G., Forman, S.J., McSweeney, P. & Storb, R. (2003) Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood, 102, 34473454.
  • Maschan, A.A., Skorobogatova, E.V., Balashov, D.N., Pashanov, E.D., Trakhtman, P.E., Schipitzina, I.P., Skvortsova, Y.V. & Rumiantzev, A.G. (2002) Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplantation, 30, 405407.
  • O'Donnell, M.R. (2004) Blood group incompatibilities and hemolytic complications of hematopoietic cell transplantation. In: Thomas’ Hematopoietic Cell Transplantation, 3rd edn (ed. by K.G.Blume, S.J.Forman & F.R.Applebaum), pp. 824832. Blackwell Publishing, Malden, MA.
  • Petz, L. & Garratty, G. (2004) Immune hemolysis associated with transplantation. In: Immune Hemolytic Anemias, 2nd edn (ed. by L.Petz & G.Garraty), pp. 459516. Churchill Livingstone, Philadelphia PA.
  • Pope, B., Brown, R., Gibson, J. & Joshua, D. (1999) The plasma cell labeling index by flow cytometry. Cytometry, 38, 286292.
  • Rowley, S.D. (2001) Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplantation, 28, 315321.
  • Stasi, R., Brunetti, M., Stipa, E. & Amadori, S. (2004) Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood, 103, 44244428.
  • Worel, N., Greinix, H.T., Schneider, B., Kurz, M., Rabitsch, W., Knobl, P., Reiter, E., Derfler, K., Fischer, G., Hinterberger, W., Hocker, P. & Kalhs, P. (2000) Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion, 40, 543550.
  • Zaucha, J.M., Mielcarek, M., Takatu, A., Little, M.T., Gooley, T., Baker, J., Maloney, D.G., Sandmaier, B.M., Maris, M., Chauncey, T., Storb, R. & Torok-Storb, B. (2002) Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. British Journal of Haematology, 119, 740750.
  • Zecca, M, Nobili, B., Ramenghi, U., Perrotta, S., Amendola, G., Rosito, P., Jankovic, M., Pierani, P., De Stefano, P., Bonora, M.R. & Locatelli, F. (2003) Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood, 101, 38573861.